semaglutide oral glp 1 FDA Approves as the First Oral GLP-1 Pill Novel GLP-1 Pill Tops Oral

Ribupatide's Phase 2 data (23.6% at 36 weeks) is promising but from a smaller Chinese-only study

Toujeo should not be used if it looks cloudy, colored, or contains particles

Initially, many patients notice a significant reduction in hunger and a greater sense of fullness within the first few weeks as the dose is gradually increased

Warning signs include persistent fatigue despite adequate sleep, cold intolerance (especially cold hands and feet), menstrual irregularity or cessation in female subjects, hair thinning or shedding, and mood disturbances (irritability, low motivation)

How much do Wegovy and Mounjaro cost